Good Days Ahead outperforms usual care in groundbreaking primary care depression study


Patients see significant improvements in symptoms and remission rates using CCBT

NEWPORT BEACH, CALIFORNIA, USA, March 16, 2022 / — MindStreet, Inc., a leading digital therapy company that develops clinically validated, evidence-based programs for mental health conditions, today announced the results of its third multisite randomized controlled study. The study used MindStreet’s pioneering digital therapy program to treat symptoms of depression in a primary care setting which yielded significantly better results than usual care. The results of the study are available in Open JAMA Network.

Depression is one of the most common mental health disorders, affecting 17% of the population. Usual care for depression may consist of a variety of treatment modalities, including cognitive behavioral therapy (CBT), a talk-based depression treatment protocol that has been used for decades. However, a full CBT course can take 16-20 clinician hours to deliver.

Computer-assisted cognitive behavioral therapy (CCBT) uses digital tools to deliver clinician-monitored CBT asynchronously, which expands access, reduces costs, and is more efficient and convenient for providers and patients. The most recent randomized controlled trial, funded by the NIH, used Good Days Ahead (GDA), MindStreet’s proprietary CCBT program, in addition to usual care to help treat symptoms of depression in adults. The results showed almost double the post-treatment response rate and more than double the remission rates for GDA plus usual care, compared to usual care alone, with benefits that were maintained six months after treatment.

“Two out of five American adults report symptoms of depression or anxiety, according to a recent report from the Kaiser Family Foundation. Unfortunately, traditional mental health systems are overwhelmed by a severe shortage of providers, while stigma and cost impede access and care,” said Jess Wright, MD, Ph.D., Professor and director of the University of Louisville Depression Center and chief medical adviser. at MindStreet, Inc. “Using CCBT to develop effective and efficient treatments for depression has been my research interest for over 30 years. The latest of our three randomized controlled studies demonstrates that CCBT can provide better outcomes and remission rates in a fraction of the time and cost of usual care in a primary care setting.

“The demand for mental health services far exceeds the available resources. This imbalance has reached crisis levels globally due to the pandemic, social instability and now, escalating geopolitical conflict,” said Valerie Ramirez Mukherjee, Founder and Executive Chairperson of MindStreet. . “MindStreet is thrilled to build on Dr. Wright’s fundamental research into developing scalable digital solutions that are accessible, affordable and stigma-free to help expand mental health coverage and care.” »

Cognitive-behavioral therapy (CBT) has established itself as an effective treatment for people with mental disorders. However, CBT can be time-consuming and expensive to provide, which can lead to delayed or denied care. Founded by pioneers of computer-based cognitive behavioral therapy (CBT), MindStreet’s programs systematize and accelerate the delivery of CBT without losing protocol fidelity. MindStreet’s proprietary CCBT platform draws on decades of research to treat mental health disorders that can help alleviate the global mental health crisis.

MindStreet, Inc. is a leading digital therapy company that develops and distributes clinically validated, evidence-based programs for mental health. Its proprietary computer-assisted cognitive-behavioral therapy (CCBT) platform is backed by decades of NIH-funded research. The platform includes unique content, technology, delivery and engagement tools to rapidly, systematically and asynchronously deliver CBT for mental health issues. MindStreet currently has programs for depression and chronic pain, with several more in development. These programs are immediately accessible and designed to be highly resource, time and cost efficient, with clinical results comparable to a full CBT course. Based in Newport Beach, California, the company was founded in 2020 and its mission is to make mental health treatment accessible, affordable and stigma-free.

Chelsea Waite
PR of pink shark
[email protected]


Comments are closed.